biotech funding

R.A. Session II

Success in the Genes: Launching in a Pandemic Didn’t Hurt This Fast-Growth Dallas Biotech Company

by | Feb 26, 2021
In under six months, Taysha Gene Therapies rocketed from the unveiling of its UTSW spinout to a $157 million initial public offering. We talk with Founder and CEO R.A. Session II about the biotech with big plans.
MORE►
Riding the Funding Wave: These DFW Startups Got the Money in 2020
by | Feb 11, 2021
Here are 32 North Texas startups that successfully pulled in capital to back their ventures. Fitting the digital demands of a global pandemic, it's a tech-heavy group, with liberal doses of biotech and healthcare-related firms.
MORE►
Caris Life Sciences Raises $310M to Continue Rapidly Growing in the Precision Medicine Market
by | Oct 27, 2020
The growth capital will allow Caris to advance its position as a leading tumor profiling company that aims to reinvent cancer care.
MORE►
A Special Thank you to our sponsors

A collaboration of the Dallas Regional Chamber and Dallas Next, Dallas Innovates is an online news platform covering what's new + next in Dallas - Fort Worth innovation.

© Copyright 2024 | All rights reserved.

Business

Creative

Education

Impact

Invention

Startup

Our Sponsors

Our Partners